- Datum28.04.2025
- Uhrzeit08:00 - 09:00 Uhr
- Veranstalter
XTB
Altan Cantürk
Moderator
Sonoma Pharmaceuticals Inc. Aktie
Verkaufen
Kaufen
Sonoma Pharmaceuticals Inc. Chart
Sonoma Pharmaceuticals Inc. Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| L&S weekend | VK | |||||
| Nasdaq | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
9,59 %
Intraday
83,91 %
1 Woche
34,71 %
1 Monat
57,25 %
Seit Jahresbeginn
33,02 %
1 Jahr
-92,08 %
3 Jahre
-95,57 %
5 Jahre
Passender Service zu Sonoma Pharmaceuticals Inc.
Webinar zu Sonoma Pharmaceuticals Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)1,750-9,374
- Jahrestief / Hoch ($)1,750-4,460
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Sonoma Pharmaceuticals Inc.
Keine Dividenden verfügbar
Termine von Sonoma Pharmaceuticals Inc.
Keine aktuellen Termine
Beschreibung
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, and other countries.
